Compositions and methods for inhibiting expression of Factor VII gene

Details for Australian Patent Application No. 2008335202 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Akinc, Akin; De Fougerolles, Antonin; Novobrantseva, Tatiana

Agent FB Rice

Pub. Number AU-A-2008335202

PCT Pub. Number WO2009/076400

Priority 61/014,879 19.12.07 US; 61/012,670 10.12.07 US

Filing date 10 December 2008

Wipo publication date 18 June 2009

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/076400 Priority application(s): WO2009/076400

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008335203-Battery separator structures

2008335196-Light source tracker